TapImmune (NASDAQ:TPIV) slips 9% premarket on the heels of its announced private placement of 17.5M common shares at $4/share. Investors will also receive five-year warrants to purchase up to 13.125M shares at $5.
The transaction should close by the end of next quarter.
Yesterday's close was $5.95.
Now read: Abaxis May Not Receive A New Offer »
Subscribe for full text news in your inbox